These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
150 related articles for article (PubMed ID: 25937014)
61. Design and synthesis of novel tetrahydronaphthyl azoles and related cyclohexyl azoles as antileishmanial agents. Marrapu VK; Srinivas N; Mittal M; Shakya N; Gupta S; Bhandari K Bioorg Med Chem Lett; 2011 Mar; 21(5):1407-10. PubMed ID: 21295472 [TBL] [Abstract][Full Text] [Related]
62. Diastereoselective synthesis of substituted hexahydrobenzo[de]isochromanes and evaluation of their antileishmanial activity. Saikia AK; Sultana S; Devi NR; Deka MJ; Tiwari K; Dubey VK Org Biomol Chem; 2016 Jan; 14(3):970-9. PubMed ID: 26625982 [TBL] [Abstract][Full Text] [Related]
63. In vitro activity of Triclisia patens and some bisbenzylisoquinoline alkaloids against Leishmania donovani and Trypanosoma brucei brucei. del Rayo Camacho M; Phillipson JD; Croft SL; Rock P; Marshall SJ; Schiff PL Phytother Res; 2002 Aug; 16(5):432-6. PubMed ID: 12203262 [TBL] [Abstract][Full Text] [Related]
64. Molecular Modeling and Virtual Screening Approach to Discover Potential Antileishmanial Inhibitors Against Ornithine Decarboxylase. Pandey RK; Prajapati P; Goyal S; Grover A; Prajapati VK Comb Chem High Throughput Screen; 2016; 19(10):813-823. PubMed ID: 27604958 [TBL] [Abstract][Full Text] [Related]
66. Discovery of a new antileishmanial hit in 8-nitroquinoline series. Paloque L; Verhaeghe P; Casanova M; Castera-Ducros C; Dumètre A; Mbatchi L; Hutter S; Kraiem-M'rabet M; Laget M; Remusat V; Rault S; Rathelot P; Azas N; Vanelle P Eur J Med Chem; 2012 Aug; 54():75-86. PubMed ID: 22608675 [TBL] [Abstract][Full Text] [Related]
67. A new series of amodiaquine analogues modified in the basic side chain with in vitro antileishmanial and antiplasmodial activity. Guglielmo S; Bertinaria M; Rolando B; Crosetti M; Fruttero R; Yardley V; Croft SL; Gasco A Eur J Med Chem; 2009 Dec; 44(12):5071-9. PubMed ID: 19811859 [TBL] [Abstract][Full Text] [Related]
68. Febrifugine analogues as Leishmania donovani trypanothione reductase inhibitors: binding energy analysis assisted by molecular docking, ADMET and molecular dynamics simulation. Pandey RK; Kumbhar BV; Srivastava S; Malik R; Sundar S; Kunwar A; Prajapati VK J Biomol Struct Dyn; 2017 Jan; 35(1):141-158. PubMed ID: 27043972 [TBL] [Abstract][Full Text] [Related]
69. Interactions of antiparasitic alkaloids with Leishmania protein targets: a molecular docking analysis. Ogungbe IV; Ng JD; Setzer WN Future Med Chem; 2013 Oct; 5(15):1777-99. PubMed ID: 24144413 [TBL] [Abstract][Full Text] [Related]
70. Chemotherapy of leishmaniasis part XIII: design and synthesis of novel heteroretinoid-bisbenzylidine ketone hybrids as antileishmanial agents. Tiwari A; Kumar S; Shivahare R; Kant P; Gupta S; Suryawanshi SN Bioorg Med Chem Lett; 2015 Jan; 25(2):410-3. PubMed ID: 25475205 [TBL] [Abstract][Full Text] [Related]
71. Synthesis and biological evaluation of new [1,2,4]triazino[5,6-b]indol-3-ylthio-1,3,5-triazines and [1,2,4]triazino[5,6-b]indol-3-ylthio-pyrimidines against Leishmania donovani. Gupta L; Sunduru N; Verma A; Srivastava S; Gupta S; Goyal N; Chauhan PM Eur J Med Chem; 2010 Jun; 45(6):2359-65. PubMed ID: 20371140 [TBL] [Abstract][Full Text] [Related]
72. Effect of pyrazoloquinoline derivatives on the growth of Leishmania donovani promastigotes. Al-Qahtani A; Siddiqui YM; Bekhit AA; El-Sayed OA; Aboul-Enein HY; Al-Ahdalb MN Arch Pharm (Weinheim); 2005 Oct; 338(10):484-7. PubMed ID: 16211660 [TBL] [Abstract][Full Text] [Related]